Reuters logo
Bristol-Myers quarterly profit beats forecasts
2015年1月27日 / 下午12点57分 / 3 年前

Bristol-Myers quarterly profit beats forecasts

Jan 27 (Reuters) - Bristol-Myers Squibb Co reported higher-than-expected quarterly earnings, helped by surprisingly strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.

The U.S. drugmaker on Tuesday said it earned $13 million, or 1 cent per share, in the fourth quarter. That compared with $726 million, or 44 cents per share, a year earlier.

Excluding special items, including an after-tax charge of 28 cents per share resulting from the transfer of U.S. pension obligations, Bristol-Myers earned 46 cents per share. Analysts on average expected 41 cents.

Revenue fell 4 percent to $4.26 billion, coming in above Wall Street expectations of $4.03 billion. Sales would have fallen only 1 percent if not for the stronger dollar, which reduces the value of sales abroad. (Reporting by Ransdell Pierson; Editing by Lisa Von Ahn)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below